References
- Warren JW. Catheter-associated urinary tract infections. Int J Antimicrob Agents 2001; 17: 299–303.
- Guidelines for preventing infections associated with the insertion and the maintenance of short-term indwelling ure-thral catheter in acute care. J. Hosp Infect 2001; 47 (suppl): S39-S46.
- Stamm WE. Guidelines for prevention of catheter-associ-ated urinary tract infections. Ann Intern Med. 1975; 82: 386–390.
- Saints S, Lipsky BA. Preventing catheter-related bacteri-uria: should we? Can we? How? Arch Intern Med. 1999; 159: 800-808.
- Bisset L. Reducing the risk of catheter-related urinary tract infection. Nurs Times. 2005; 101: 64-65, 67.
- Nicolle LE. Catheter-related urinary tract infection. Drugs Aging. 2005; 22: 627–639.
- Ippolito G, Gesu G, Giuliani L, Marchetti F, Privitera G and the Inf-Nos Study Group. Prevalence of nosocomial infec-tions in Italy: results of the INF NOS Project in the year 2003. 15th European Congress of Clinical Microbiology and Infectious Diseases Copenhagen, Denmark 2-5 April 2005, Clinical Microbiology and Infection 2005; 11 (Suppl 2) P1902.
- Tambyah PA, Maki DG. The relationship between pyuria and infection in patients with indwelling urinary catheters: a prospective study of 761 patients. Arch Intern Med. 2000; 160: 673–677.
- Stark RP, Maki DG. Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? N Engl J Med. 1984; 311: 560–564.
- Warren JW. Catheter-associated urinary tract infections. Infect Dis Clin North Am. 1997; 11: 609–622.
- Platt R, Polk BF, Murdock B, Rosner B. Risk factors for nosocomial urinary tract infection. Am J Epidemiol. 1986; 124: 977–985.
- Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002; 113 Suppl 1A:5S - 13S
- Haley RW, Hooton TM, Culver DH et al. Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. Am J Med 1981; 70: 947–959.
- Warren J. W Antibiotic irrigation and catheter-associat-ed urinary-tract infections. N Engl J Med 1978; 299: 570–573.
- Tambyah PA, Maki DG. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med. 2000; 160: 678–682.
- Warren JW. Fever, bacteremia, and death as complica-tions of bacteriuria in women with long-term urethral catheters. J Infect Dis. 1987; 155: 1151–1158.
- Muder RR, Brennen C, Wagener MM, Goets AM. Bacteremia in a long-term-care facility: a five-year prospective study of 163 consecutive episodes. Clin Infect Dis. 1992; 14: 647–654.
- Platt R, Polk BF, Murdock B, Rosner B. Mortality asso-ciated with nosocomial urinary-tract infection. N Engl J Med 1982; 307: 637–642.
- Wazait HD, Patel HRH, Veer V et al. Catheter-associ-ated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996-2001). BJU Int. 2003; 91: 806–809.
- Garibaldi RA, Burke JP, Britt MR et al. Meatal colo-nization and catheter-associated bacteriuria. N Engl J Med. 1980; 303: 316–318.
- Britt MR, Garibaldi RA, Miller WA et al. Antimicrobial prophylaxis for catheter-associated bacteriuria. Antimicrob Agents Chemother. 1977; 11: 240–243.
- Sedor J, Mulholland SG. Hospital-acquired urinary tract infections associated with the indwelling catheter. Urol Clin North Am. 1999; 26: 821–828.
- Richard GA, Klimberg IN, Fowler CL et al. Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis. Urology. 1998; 52: 51–55.
- Croom KF, Goa KL. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States. Drugs. 2003; 63: 2769–2802.
- Leone M, Gamier F, Avidan M, et al. Catheter-associ-ated urinary tract infections in intensive care units. Microbes Infect. 2004; 6: 1026–1032.
- Saint S, Savel RH, Matthay MA. Enhancing the safety of critically ill patients by reducing urinary and central venous catheter-related infections. Am J Respir Crit Care Med. 2002; 165: 1475–1479.
- Stamm WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med. 1991; 91:65S-71S.
- Hustinx WN, Mintjes-de Groot AJ, Verkooyen RP, Verbrugh HA. Impact of concurrent antimicrobial therapy on catheter-associated urinary tract infection. J Hosp Infect. 1991; 18: 45–56.
- Vollaard EJ, Cleasener HA, Zambon JV, Joosten HJ, van Griettuysen AJ. Prevention of catheter-associated gram-negative bacilluria with norfloxacin by selective decontamina-tion of the bowel and high urinary concentration. J Antimicrob Chemother. 1989; 23: 915–922.
- Verbrugh HA, Mintjes-de Groot AJ, Andriesse R, Hamersma K, van Dijk A. Postoperative prophylaxis with nor-floxacin in patients requiring bladder catheters. Eur J Clin Microbiol Infect Dis. 1988; 7: 490–494.
- Little OJ, Pearson S, Peddie BA, Greenslade NF, Utley WL. Amoxicillin in the prevention of catheter-induced urinary infection. J Infect Dis. 1974; 129: suppl: S241-S242.
- Catheter-acquired urinary tract infection. Lancet. 1991; 338: 857–858.
- Van der Walls E, Verkooyen RP, Mintjes-de Groot AJ et al. Prophylactic ciprofloxacin for catheter-associated uri-nary-tract infection. Lancet. 1992; 339: 946–951.
- Salvestrini F, Oliva G, Mattei FM. Oral therapy with ciprofloxacin in the prophylaxis of urinary infections in surgi-cal patients with permanent bladder catheter. Minerva Chir. 1996; 51: 625–628.